Previous Close | 24.36 |
1-Year Change | 101.16% |
6-Months Change | 86.81% |
3-Months Change | 30.69% |
Moving Avg (50d) | 20.928 |
Moving Avg (200d) | 16.315 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.987B |
Beta (3-Years) | 0.79 |
Revenue Growth (ttm) | 1.73% |
Net Profit Margin (ttm) | 2.12% |
Return On Assets (ttm) | 2.15% |
EPS (ttm) | 0.52 |
PE Ratio (ttm) | 46.85 |
Dividend Yield | 1.97% |
Asset Description: | Phibro Animal Health Corporation |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-10-09 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
23.873 | 23.142 | 22.655 | 21.924 | 20.706 | 19.488 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |